A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2016-08-30
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to evaluate the effect of ASP1707 twice daily on the
pharmacokinetics of once weekly oral methotrexate (MTX).
This study will also evaluate the effect of MTX on multiple-dose pharmacokinetics of ASP1707,
as well as safety and tolerability of coadministration of ASP1707 and MTX in patients with
rheumatoid arthritis (RA).